Gastroesophageal Reflux Disease Therapeutics Market - Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: GDD1D312587AEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Flame Retardant Plastic Granule in global, including the following market information:

Global Flame Retardant Plastic Granule Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Flame Retardant Plastic Granule Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Flame Retardant Plastic Granule companies in 2021 (%)

The global Flame Retardant Plastic Granule market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Flame Retardant ABS Granules Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Flame Retardant Plastic Granule include Ahd Thermoplastics Industries, Shanghai Info New Material Technology and Shenzhen Sunshine Chemical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Flame Retardant Plastic Granule manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Flame Retardant Plastic Granule Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Flame Retardant Plastic Granule Market Segment Percentages, by Type, 2021 (%)

• Flame Retardant ABS Granules
• Flame Retardant PP Granules
• Flame Retardant TPE Granules

Global Flame Retardant Plastic Granule Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Flame Retardant Plastic Granule Market Segment Percentages, by Application, 2021 (%)

• Electronics
• Chemical
• Other

Global Flame Retardant Plastic Granule Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Flame Retardant Plastic Granule Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Flame Retardant Plastic Granule revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Flame Retardant Plastic Granule revenues share in global market, 2021 (%)

Key companies Flame Retardant Plastic Granule sales in global market, 2017-2022 (Estimated), (MT)

Key companies Flame Retardant Plastic Granule sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Ahd Thermoplastics Industries
• Shanghai Info New Material Technology
• Shenzhen Sunshine Chemical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gastroesophageal Reflux Disease Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gastroesophageal Reflux Disease Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size: 2021 VS 2028
2.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gastroesophageal Reflux Disease Therapeutics Players in Global Market
3.2 Top Global Gastroesophageal Reflux Disease Therapeutics Companies Ranked by Revenue
3.3 Global Gastroesophageal Reflux Disease Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Gastroesophageal Reflux Disease Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gastroesophageal Reflux Disease Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gastroesophageal Reflux Disease Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Gastroesophageal Reflux Disease Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gastroesophageal Reflux Disease Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Gastroesophageal Reflux Disease Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Antacids
  4.1.3 H2 Receptor Blockers
  4.1.4 Proton Pump Inhibitors (PPIs)
  4.1.5 Pro-kinetic Agents
  4.1.6 Others
4.2 By Type - Global Gastroesophageal Reflux Disease Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Gastroesophageal Reflux Disease Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Gastroesophageal Reflux Disease Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gastroesophageal Reflux Disease Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Drug Stores
  5.1.4 General Stores
  5.1.5 Supermarkets
5.2 By Application - Global Gastroesophageal Reflux Disease Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Gastroesophageal Reflux Disease Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Gastroesophageal Reflux Disease Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Gastroesophageal Reflux Disease Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Gastroesophageal Reflux Disease Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Gastroesophageal Reflux Disease Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Gastroesophageal Reflux Disease Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Gastroesophageal Reflux Disease Therapeutics Revenue, 2017-2028
  6.3.2 US Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.3.3 Canada Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Gastroesophageal Reflux Disease Therapeutics Revenue, 2017-2028
  6.4.2 Germany Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.4.3 France Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.4.5 Italy Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.4.6 Russia Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Gastroesophageal Reflux Disease Therapeutics Revenue, 2017-2028
  6.5.2 China Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.5.3 Japan Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.5.6 India Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Gastroesophageal Reflux Disease Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.7.3 Israel Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028
  6.7.5 UAE Gastroesophageal Reflux Disease Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Major Product Offerings
  7.1.4 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 Eisai
  7.2.1 Eisai Corporate Summary
  7.2.2 Eisai Business Overview
  7.2.3 Eisai Gastroesophageal Reflux Disease Therapeutics Major Product Offerings
  7.2.4 Eisai Gastroesophageal Reflux Disease Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Eisai Key News
7.3 Takeda Pharmaceutical
  7.3.1 Takeda Pharmaceutical Corporate Summary
  7.3.2 Takeda Pharmaceutical Business Overview
  7.3.3 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Major Product Offerings
  7.3.4 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Takeda Pharmaceutical Key News
7.4 GlaxoSmithKline
  7.4.1 GlaxoSmithKline Corporate Summary
  7.4.2 GlaxoSmithKline Business Overview
  7.4.3 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Major Product Offerings
  7.4.4 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 GlaxoSmithKline Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Major Product Offerings
  7.5.4 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Johnson & Johnson Key News
7.6 Daewoong Pharmaceutical
  7.6.1 Daewoong Pharmaceutical Corporate Summary
  7.6.2 Daewoong Pharmaceutical Business Overview
  7.6.3 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Major Product Offerings
  7.6.4 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Daewoong Pharmaceutical Key News
7.7 Ironwood Pharmaceuticals
  7.7.1 Ironwood Pharmaceuticals Corporate Summary
  7.7.2 Ironwood Pharmaceuticals Business Overview
  7.7.3 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Major Product Offerings
  7.7.4 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Ironwood Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Gastroesophageal Reflux Disease Therapeutics Market Opportunities & Trends in Global Market
Table 2. Gastroesophageal Reflux Disease Therapeutics Market Drivers in Global Market
Table 3. Gastroesophageal Reflux Disease Therapeutics Market Restraints in Global Market
Table 4. Key Players of Gastroesophageal Reflux Disease Therapeutics in Global Market
Table 5. Top Gastroesophageal Reflux Disease Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gastroesophageal Reflux Disease Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gastroesophageal Reflux Disease Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gastroesophageal Reflux Disease Therapeutics Product Type
Table 9. List of Global Tier 1 Gastroesophageal Reflux Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastroesophageal Reflux Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gastroesophageal Reflux Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gastroesophageal Reflux Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gastroesophageal Reflux Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gastroesophageal Reflux Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gastroesophageal Reflux Disease Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gastroesophageal Reflux Disease Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Gastroesophageal Reflux Disease Therapeutics Product Offerings
Table 32. AstraZeneca Gastroesophageal Reflux Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Eisai Corporate Summary
Table 34. Eisai Gastroesophageal Reflux Disease Therapeutics Product Offerings
Table 35. Eisai Gastroesophageal Reflux Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Takeda Pharmaceutical Corporate Summary
Table 37. Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product Offerings
Table 38. Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Product Offerings
Table 41. GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Product Offerings
Table 44. Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Daewoong Pharmaceutical Corporate Summary
Table 46. Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product Offerings
Table 47. Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Ironwood Pharmaceuticals Corporate Summary
Table 49. Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Product Offerings
Table 50. Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Gastroesophageal Reflux Disease Therapeutics Segment by Type in 2021
Figure 2. Gastroesophageal Reflux Disease Therapeutics Segment by Application in 2021
Figure 3. Global Gastroesophageal Reflux Disease Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gastroesophageal Reflux Disease Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gastroesophageal Reflux Disease Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gastroesophageal Reflux Disease Therapeutics Revenue in 2021
Figure 8. By Type - Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gastroesophageal Reflux Disease Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gastroesophageal Reflux Disease Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gastroesophageal Reflux Disease Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gastroesophageal Reflux Disease Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gastroesophageal Reflux Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Gastroesophageal Reflux Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eisai Gastroesophageal Reflux Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)